{"nct_id":"NCT04502706","title":"Study of GS-0189 (Formerly FSI-189) as Monotherapy and in Combination With Rituximab in Participants With Relapsed/Refractory Non-Hodgkin Lymphoma","status":"TERMINATED","status_verified_date":"2022-05","start_date":"2020-11-17","start_date_type":"ACTUAL","primary_completion_date":"2022-03-31","primary_completion_date_type":"ACTUAL","completion_date":"2022-03-31","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GILD"]}